BRIEF-Aikido Pharma Announces Successful Initial Public Offering Of Asp Isotopes

Reuters2022-11-28

Nov 28 (Reuters) - Aikido Pharma Inc :

* AIKIDO PHARMA ANNOUNCES SUCCESSFUL INITIAL PUBLIC OFFERING OF ASP ISOTOPES

* AIKIDO PHARMA - ASPI PRICED IPO OF 1.25 MILLION SHARES OF COMMON STOCK AT A PUBLIC OFFERING PRICE OF $4.00 PER SHARE, FOR GROSS PROCEEDS OF ABOUT $5.0 MILLION

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2286591389?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2022-11-28 22:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2286591389","market":"us","top_or_hot":-1,"title":"BRIEF-Aikido Pharma Announces Successful Initial Public Offering Of Asp Isotopes","media":"Reuters","content":"<html><body><p>Nov 28 (Reuters) - Aikido Pharma Inc   :</p><p>   * AIKIDO PHARMA ANNOUNCES SUCCESSFUL INITIAL PUBLIC OFFERING OF ASP ISOTOPES</p><p>   * AIKIDO PHARMA - ASPI PRICED IPO OF 1.25 MILLION SHARES OF COMMON STOCK AT A PUBLIC OFFERING PRICE OF $4.00 PER SHARE, FOR GROSS PROCEEDS OF ABOUT $5.0 MILLION</p><p>Source text for Eikon:    Further company coverage:   </p><p>((Reuters.Briefs@thomsonreuters.com;;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Aikido Pharma Announces Successful Initial Public Offering Of Asp Isotopes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Aikido Pharma Announces Successful Initial Public Offering Of Asp Isotopes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-11-28 22:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Nov 28 (Reuters) - Aikido Pharma Inc   :</p><p>   * AIKIDO PHARMA ANNOUNCES SUCCESSFUL INITIAL PUBLIC OFFERING OF ASP ISOTOPES</p><p>   * AIKIDO PHARMA - ASPI PRICED IPO OF 1.25 MILLION SHARES OF COMMON STOCK AT A PUBLIC OFFERING PRICE OF $4.00 PER SHARE, FOR GROSS PROCEEDS OF ABOUT $5.0 MILLION</p><p>Source text for Eikon:    Further company coverage:   </p><p>((Reuters.Briefs@thomsonreuters.com;;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CGEM","symbol_name":"Cullinan Therapeutics","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2286591389","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2286591389","pubTimestamp":1669644186,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Nov 28 (Reuters) - Aikido Pharma Inc   :   * AIKIDO PHARMA ANNOUNCES SUCCESSFUL INITIAL PUBLIC OFFER","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CGEM":"Cullinan Therapeutics","BK4007":"制药","BK4196":"保健护理服务","LHDX":"Lucira Health, Inc.","ASPI":"ASP Isotopes Inc.","SANA":"Sana Biotechnology, Inc.","BK4082":"医疗保健设备","LABP":"Landos Biopharma, Inc.","BK4139":"生物科技"},"translate_title":"简介-合气道制药宣布成功首次公开发行Asp同位素","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AIKI":0.9,"APR":0.68,"ASPI":0.9,"CGEM":0.68,"LABP":0.68,"LHDX":0.68,"SANA":0.68},"content_text":"Nov 28 (Reuters) - Aikido Pharma Inc   :   * AIKIDO PHARMA ANNOUNCES SUCCESSFUL INITIAL PUBLIC OFFERING OF ASP ISOTOPES   * AIKIDO PHARMA - ASPI PRICED IPO OF 1.25 MILLION SHARES OF COMMON STOCK AT A PUBLIC OFFERING PRICE OF $4.00 PER SHARE, FOR GROSS PROCEEDS OF ABOUT $5.0 MILLIONSource text for Eikon:    Further company coverage:   ((Reuters.Briefs@thomsonreuters.com;;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2286591389"}